Kirsten Overgaard

484 total citations
11 papers, 379 citations indexed

About

Kirsten Overgaard is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Kirsten Overgaard has authored 11 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Orthopedics and Sports Medicine, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Kirsten Overgaard's work include Bone health and osteoporosis research (9 papers), Bone Metabolism and Diseases (4 papers) and Estrogen and related hormone effects (3 papers). Kirsten Overgaard is often cited by papers focused on Bone health and osteoporosis research (9 papers), Bone Metabolism and Diseases (4 papers) and Estrogen and related hormone effects (3 papers). Kirsten Overgaard collaborates with scholars based in Denmark, Sweden and Italy. Kirsten Overgaard's co-authors include M.A. Hansen, Claus Christiansen, Bente Juel Riis, Claus Christiansen, Pernille Ravn, Merete Lund Hetland, D. Agnusdei, Emanuela Maioli, C. Gennari and Robert Lindsay and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Medicine and Journal of Bone and Mineral Research.

In The Last Decade

Kirsten Overgaard

11 papers receiving 360 citations

Peers

Kirsten Overgaard
H Minne Germany
Seung Kil Lim South Korea
Sung Hee Ihm South Korea
B. M. Ingle United Kingdom
E. Puntila Finland
M. Tezval Germany
Kirsten Overgaard
Citations per year, relative to Kirsten Overgaard Kirsten Overgaard (= 1×) peers Carlo Valtorta

Countries citing papers authored by Kirsten Overgaard

Since Specialization
Citations

This map shows the geographic impact of Kirsten Overgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Overgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Overgaard more than expected).

Fields of papers citing papers by Kirsten Overgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten Overgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Overgaard. The network helps show where Kirsten Overgaard may publish in the future.

Co-authorship network of co-authors of Kirsten Overgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten Overgaard. A scholar is included among the top collaborators of Kirsten Overgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten Overgaard. Kirsten Overgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Overgaard, Kirsten, Robert Lindsay, & Claus Christiansen. (1995). Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study. Clinical Therapeutics. 17(4). 680–685. 19 indexed citations
2.
Overgaard, Kirsten, et al.. (1995). Postmenopausal Bone Loss and Response to Hormone Replacement Therapy Independent of Climacteric Symptoms. Menopause The Journal of The North American Menopause Society. 2(1). 35???42–35???42. 2 indexed citations
3.
Ravn, Pernille, Agneta Bergqvist, M.A. Hansen, Kirsten Overgaard, & Claus Christiansen. (1994). Treatment of Endometriosis with the Luteinizing Hormone-Releasing Hormone Agonist Nafarelin. Effect on Bone Turnover and Bone Mass. Menopause The Journal of The North American Menopause Society. 1(1). 11???18–11???18. 6 indexed citations
4.
Overgaard, Kirsten & Bente Juel Riis. (1994). Nasal salmon calcitonin in osteoporosis. Calcified Tissue International. 55(2). 79–81. 18 indexed citations
5.
Ravn, Pernille, Merete Lund Hetland, Kirsten Overgaard, & Claus Christiansen. (1994). Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy x-ray absorptiometry. Journal of Bone and Mineral Research. 9(12). 1975–1980. 85 indexed citations
6.
Overgaard, Kirsten, et al.. (1992). Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis. Calcified Tissue International. 51(3). 184–188. 20 indexed citations
7.
Overgaard, Kirsten, M.A. Hansen, Bente Juel Riis, & Claus Christiansen. (1992). Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women. Calcified Tissue International. 50(1). 30–35. 61 indexed citations
8.
Overgaard, Kirsten, D. Agnusdei, M.A. Hansen, et al.. (1991). Dose-Response Bioactivity and Bioavailability of Salmon Calcitonin in Premenopausal and Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 72(2). 344–349. 54 indexed citations
9.
Overgaard, Kirsten & Claus Christiansen. (1991). Long-term treatment of established osteoporosis with intranasal calcitonin. Calcified Tissue International. 49(S1). S60–S63. 29 indexed citations
10.
Overgaard, Kirsten, et al.. (1990). Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment. The American Journal of Medicine. 89(1). 1–6. 76 indexed citations
11.
Hartwell, Dorthe, Christian Hassager, Kirsten Overgaard, et al.. (1990). Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin. European Journal of Endocrinology. 122(6). 715–721. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026